Joel Isaacson & Co’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Joel Isaacson & Co’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-100	Closed	-$9K	–	296
2016 Q4	$9K	Hold	100	–	–	﹤0.01%	512
2016 Q3	$10K	Buy	+100	New	+$9.81K	﹤0.01%	538
2016 Q2	–	Sell	-560	Closed	-$49K	–	736
2016 Q1	$49K	Hold	560	–	–	0.01%	336
2015 Q4	$63K	Hold	560	–	–	0.02%	298
2015 Q3	$57K	Buy	+560	New	+$66.6K	0.02%	319

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

MCWS

McKinley Carter Wealth Services Wheeling, West Virginia $1.73B AUM 17.28% 1-Year Est. Return

JPCCM

J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return

Joel Isaacson & Co's FBT Position: Q1 2017 in Review

Joel Isaacson & Co sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2017, closing a stake of 100 shares — an estimated $9K sold.

Joel Isaacson & Co first reported a position in FBT in Q3 2015 and held it in 5 quarters. The position peaked at $63K in Q4 2015. 113 funds tracked by Wall St. Rank hold FBT as of Q1 2017.

Joel Isaacson & Co reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2017 after selling out during the quarter.
Joel Isaacson & Co sold 100 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2017, an estimated $9K.
Joel Isaacson & Co first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2015 and held it in 5 quarters.
Joel Isaacson & Co's First Trust NYSE Arca Biotechnology Index Fund position peaked at $63K in Q4 2015.
113 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2017.

Based on Joel Isaacson & Co's 13F filing for Q1 2017, filed 5 May 2017.